Page last updated: 2024-10-26

ethyl loflazepate and Chronic Kidney Failure

ethyl loflazepate has been researched along with Chronic Kidney Failure in 1 studies

ethyl loflazepate: structure given in first source

Research Excerpts

ExcerptRelevanceReference
" In contrast, elimination half-life and total plasma clearance of the sum of loflazepate + descarboxyloflazepate seemed to be independent of the degree of renal impairment."1.28Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man. ( Ba, BB; Berger, Y; Cano, JP; Durand, A; Iliadis, A; Necciari, J, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ba, BB1
Iliadis, A1
Durand, A1
Berger, Y1
Necciari, J1
Cano, JP1

Other Studies

1 other study available for ethyl loflazepate and Chronic Kidney Failure

ArticleYear
Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man.
    Fundamental & clinical pharmacology, 1989, Volume: 3, Issue:1

    Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Female;

1989
chemdatabank.com